Mutations in the tat gene are responsible for human immunodeficiency virus type 1 postintegration latency in the U1 cell line

Journal of Virology

Volumn 72, Issue 2, 1998, Pages 1666-1670

  Emiliani, Stephane ^a   Fischle, Wolfgang ^a   Ott, Melanie ^a   Van Lint, Carine ^a   Amella, Carol Ann ^a   Verdin, Eric ^a,b  

^a PICOWER INST FOR MEDICAL RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LEUKEMIA CELL LINE; LONG TERMINAL REPEAT; MONOCYTE; PRIORITY JOURNAL; REPORTER GENE; TRANSACTIVATION; VIRUS LATENCY;

EID: 0031931047     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.2.1666-1670.1998     Document Type: Article

References (26)

1. Adams, M., L. Sharmeen, J. Kimpton, J. M. Romeo, J. V. Garcia, B. M. Peterlin, M. Groudine, and M. Emerman. 1994. Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected hy the presence of promoter-proximal transcripts. Proc. Natl. Acad. Sci. USA 91:3862-3866.
2. Cannon, P., S. H. Kim, C. Ulich, and S. Kim. 1994. Analysis of Tat function in human immunodeficiency virus type 1-infected low-level-expression cell lines U1 and ACH-2. J. Virol. 68:1993-1997.
3. Chen, B. K., K. Saksela, R. Andino, and D. Baltimore. 1994. Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by super-infection of nonproductively infected cell lines with recombinant luciferase-encoding viruses. J. Virol. 68:654-660.
4. Chun, T. W., L. Carruth, D. Finzi, X. Shen, J. A. Digiuseppe, H. Taylor, M. Hermankova, K. Chadwick, J. Margolick, T. C. Quinn, Y.-H. Kuo, R. Brookmeyer, M. A. Zeiger, P. Barditch-Crovo, and R. F. Siliciano. 1997. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387:183-188.
5. Coffin, J. M. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267:483-189.
6. Delassus, S., A. Meyerhans, R. Cheynier, and S. Wain-Hobson. 1992. Absence of selection of HIV-1 variants in vivo based on transcription/transactivation during progression to AIDS. Virology 188:811-818.
7. Duan, L., J. W. Oakes, A. Ferraro, O. Bagasra, and R. J. Pomerantz. 1994. Tat and rev differentially affect restricted replication of human immunodeficiency virus type 1 in various cells. Virology 199:474-478.
8. Embretson, J., M. Zupancic, J. L. Ribas, A. Burke, P. Racz, K. Tenner-Racz, and A. T. Haase. 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362: 359-362.
9. Emiliani, S., C. Van Lint, W. Fischle, P. Paras, M. Ott, J. Brady, and E. Verdin. 1996. A point mutation in the HIV-1 tat responsive element is associated with post-integration latency. Proc. Natl. Acad. Sci. USA 93:6377-6381.
10. Feinberg, M. B., D. Baltimore, and A. D. Frankel. 1991. The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proc. Natl. Acad. Sci. USA 88:4045-4049.
11. Folks, T., J. Justement, A. Kinter, C. Dinarello, and A. Fauci. 1987. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 238:800-802.
12. Folks, T., J. Justement, A. Kinter, S. Schnittman, J. Orenstein, G., Poli, and A. Fauci. 1988. Characterization of a promonocytic clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. J. Immunol. 140:1117-1122.
13. Griffin, G. E., K. Leung, T. M. Folks, S. Kunkel, and G. J. Nabel. 1989. Activation of HIV gene expression during monocyte differentiation by induction of NF-kappa B. Nature 339:70-73.
14. Hu, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126.
15. Kinter, A., G. Poli, W. Maury, T. Folks, and A. Fauci. 1990. Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells. J. Virol. 64:4306-4312.
16. Leonard, J., C. Parrott, A. J. Buckler-White, W. Turner, E. K. Ross, M. A. Martin, and A. B. Rabson. 1989. The NF-κB binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity. J. Virol. 63:4919-4924.
17. Leonard, J. M., C. M. Parrott, A. Buckler-White, M. A. Martin, and A. B. Rabson. 1989. Characterization of the infectivity of HIV proviruses containing mutations in LTR regulatory sequences. Int. Conf. AIDS 5:582.
18. Myers, G., J. A. Berzofsky, B. Korber, R. F. Smith, and G. N. Pavlakis (ed.). 1995. Human retroviruses and AIDS. A compilation and analysis of nucleic acid and amino acid sequences. Los Alamos National Laboratory, Los Alamos, N.Mex.
19. Ott, M., S. Emiliani, C. Van Lint, G. Herbein, J. Lovett, N. Chirmule, T. McCloskey, S. Pahwa, and E. Verdin. 1997. Immune hyperactivation of HIV-1 infected T cells mediated by Tat and the CD28 pathway. Science 275:1481-1485.
20. Pantaleo, G., C. Graziosi, J. F. Demarest, L. Butini, M. Montroni, C. H. Fox, J. M. Orenstein, D. P. Kotler, and A. S. Fauci. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355-358.
21. Perelson, A. S., P. Essunger, Y. Cao, M. Vesanen, A. Hurley, K. Saksela, M. Markowitz, and D. D. Ho. 1997. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387:188-191.
22. Pomerantz, R. J., D. Trono, M. B. Feinberg, and D. Baltimore. 1990. Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency. Cell 61:1271-1276.
23. Rappaport, J., S.-J. Lee, K. Khalili, and F. Wong-Staal. 1989. The acidic amino-terminal region of the HIV-1 Tat protein constitutes an essential activating domain. New Biol. 1:101-110.
24. Van Lint, C., C. A. Amelia, S. Emiliani, M. John, T. Jie, and E. Verdin. 1997. Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity. J. Virol. 71:6113-6127.
25. Van Lint, C., J. Ghysdael, P. Paras, Jr., A. Burny, and E. Verdin. 1994. A transcriptional regulatory element is associated with a nuclease-hypersensitive site in the pol gene of human immunodeficiency virus type 1. J. Virol. 68:2632-2648.
26. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117-122.